Altman rules out OpenAI IPO for 2026, citing safety pace

answer: Altman says OpenAI will not IPO in 2026, citing AI safety concerns.

takeaways:

OpenAI has taken the guesswork out of its listing timeline, and the answer is bad news for anyone hoping to buy in this year. Sam Altman told Fortune editor-in-chief Alyson Shontell on 11 September that the company will not go public in 2026, the first time OpenAI has put an on-the-record date, or lack of one, on its IPO plans.

"I actually think that, given everything happening with safety, right now would be an ill-advised moment to go public, and we don't feel pressure on that," Altman said. Asked whether 2027 was the target instead, he said: "I would say not 2026," pointing to "a lot of stuff to do" on safety, alignment and coordination between industry and governments.

The statement lines up with what OpenAI has already signalled privately. The company confidentially filed for an IPO in June, and CFO Sarah Friar told staff in August that a public listing would land in 2027. Altman's comments confirm that internal timeline rather than change it, but they close off any chance of an accelerated 2026 debut.

Altman also disclosed that OpenAI has discussed pausing development at new capability levels to give safety work room to catch up, and said leading labs may be close to a joint agreement to slow development together. He added that OpenAI wants to retain the ability to make decisions that might not serve short-term investor interests, a position that sits awkwardly with the demands of public markets.

The remarks came a day after Anthropic's Dario Amodei called on the industry to "pace the frontier", a line Altman said he agreed with. Anthropic is still expected to push ahead with its own IPO, with marketing reportedly starting as early as mid-October, according to Fortune's reporting.

Altman's framing does two jobs at once: it manages investor expectations ahead of a 2027 listing while giving OpenAI cover to move slower on capability releases without looking like it is ceding ground to rivals. Tying the delay to safety, rather than valuation or market conditions, lets OpenAI set its own pace on both fronts.

The more interesting signal is the talk of coordinated slowdowns among leading labs. If OpenAI and Anthropic are genuinely converging on shared pacing, that reshapes competitive dynamics across the sector just as Anthropic prepares to test public markets first. Investors watching both companies should treat Anthropic's October marketing push as the real read on how safety concerns are pricing into AI valuations right now.

OpenAI's IPO wait grows longer as AI safety fears mount